Evidence map›Paper›PMID 36379542›Full record

ArticleSaudi medical journal2022

The prevalence of metabolic syndrome among university students in Wasit, Iraq.

Alaa H Zamil, Seenaa S Amin

Full text read
In one paragraph

Article in Saudi medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alaa H ZamilFrom the Department of Clinical Laboratory Sciences, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
Seenaa S AminFrom the Department of Clinical Laboratory Sciences, College of Pharmacy, University of Baghdad, Baghdad, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the prevalence of the metabolic syndrome (MetS) and its related risk factors in a group of healthy subjects.

methodsThis cross-sectional analytic investigation used a convenient sample of 300 apparently healthy university students from Wasit, Iraq, between October 2021 and February 2022. The data was collected using a structured direct interview with a self-administered questionnaire. Anthropometric measurements (waist circumference [WC], body mass index [BMI], height, weight, and the blood pressure), total cholesterol level, triglyceride level, high-density lipoprotein (HDL-C), and fasting blood glucose (FBG) were all measured. IDF/AHA/NHLBI criteria were used to diagnose metabolic syndrome.

resultsOverall, 41.3% of students had MetS, with female (66.9%) students having the highest frequency. The most common component of MetS was elevated FBG (98.3%), followed by increased WC (87.9%), and finally a low HDL-C level (85.4%). The following factors were found to be predisposing to MetS: being female (OR=2.32), over the age of 20 (OR=1.96), obese (OR=9.46), high consumption of fast food (OR=2.35), and physically inactive.

conclusionMetabolic syndrome prevalence and defining criteria are significantly high among Iraqi university students. Fasting blood glucose was the most common component followed by increased WC. The significant risk factors for MetS were older age, females, high BMI (≥25), low physical-activity, and eating of fast foods, and can remedy the risk if the components of the disease are reported at a younger age.

Indexed as

Metabolic SyndromeBlood GlucoseBody Mass IndexCross-Sectional StudiesFemaleHumansIraqMalePrevalenceRisk FactorsStudentsUniversitiesWaist CircumferenceBlood Glucoselifestylemetabolic syndromeprevalencerisk factorsuniversity student

Identifiers

PMID36379542
PMCPMC10043912

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read70
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.